Detecting and preventing adverse drug interactions: The potential contribution of computers in pharmacies by Kirking, Duane M. et al.
Ser. Sci. Med. Vol. 22. No. I, pp. 1-8. 1986 
Printed in Great Britain. All rights reserved 
0277-9536/X6 $3.00 + 0.00 
Copyrlghr t 19X6 Pergamon Press Lid 
DETECTING AND PREVENTING ADVERSE DRUG 
INTERACTIONS: THE POTENTIAL CONTRIBUTION 
OF COMPUTERS IN PHARMACIES 
DUANE M. KIRKING’.‘. J. WILLIAM THOMAS', FRANK J. ASCIONE' and EDDIE L. BOYD’ 
‘College of Pharmacy and ‘Department of Medical Care Organization, School of Public Health. 
The University of Michigan, 109 Observatory Street, Ann Arbor, MI 48109. U.S.A. 
Abstract-For patients taking two or more medications concurrently, interactions among the drugs can 
cause undesirable effects or negate desired responses. In modern pharmacy practice, an important role 
of the pharmacist is to detect potentially harmful interactions and take appropriate action to prevent their 
occurrence. Pharmacy computer systems offer potential for improving pharmacists’ effectiveness in the 
detection and followup of drug interactions. 
Based on a survey of southern Michigan pharmacists, relationships between computer use and 
pharmacists’ attitudes and activities in drug interaction monitoring were investigated. Respondents 
included users of two major computer systems as well as pharmacists who do not use computers. Results 
suggest that general statements cannot be made about the effect of computer use on drug interaction 
detection. Users of one of the two computer systems detected and followed up on interactions more 
frequently and were more likely to report improved knowledge of drug interactions than non-users. 
Frequencies of drug interaction detection and other related measures reported by users of the second 
computer system were similar to those for pharmacists not using computers. Computer system 
characteristics which might lead to these differences are discussed. 
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A drug interaction occurs when an effect of one drug 
is altered by the prior or concurrent administration of 
another drug. Such interactions can produce un- 
desirable effects on the patient or negate desired 
responses. For example, patients taking warfarin, an 
anticoagulant, who also receive the antiinflammatory 
drug phenylbutazone may experience serious bleed- 
ing episodes caused by an enhanced anticoagulant 
effect. 
Not all of the interactions that occur are harmful 
to the patient. Furthermore, given the same combina- 
tions of drugs, some patients may experience inter- 
actions, while, because of differences in conditions 
and other factors which are not completely under- 
stood, others do not. Nevertheless, drug interactions 
constitute a significant medical care problem. Of the 
nearly 17,000 potentially interacting drug combina- 
tions which were identified in a recent study of 
outpatient pharmacy medication records, 6.3% were 
classified as likely to result in interactions in every 
exposed patient and to represent significant medical 
risks for those patients [l]. For another 26.7%. 
interactions with potentially serious consequences 
were likely to occur in most exposed patients; and an 
additional 19.2% were classified as potentially 
significant depending upon individual patient 
conditions. 
It has been estimated that as many as 27-33% of 
patients receiving more than one prescribed medica- 
tion on an ambulatory basis are exposed to the 
possibility of interactions [I, 21. Thus, these problems 
occur frequently. with serious consequences to the 
health of affected patients. and with resulting 




Prevention of drug interaction is difficult. Physi- 
cians are not always aware of all the drugs their 
patients are taking and may unwittingly prescribe 
drugs which lead to interactions, since patients often 
fail to give complete medication information to their 
physicians. In one survey of the elderly, for example, 
only 23% of respondents having two or more physi- 
cians reported discussing with one physician the 
medications prescribed by another [4]. 
Pharmacists, however, often are in a position to 
effectively monitor for drug interactions. Since 
70-80% of patients receiving prescribed medications 
use a single pharmacy for all prescriptions [5, 61, 
pharmacists have the opportunity, as well as the 
training, to detect possible interactions and prevent 
their occurrence. For prescription medications, a 
pharmacist typically is the patient’s final contact with 
the health care system before therapy is initiated. 
Also, patients requiring continuing medication 
therapy often visit their pharmacists for refills of 
prescriptions more frequently than they visit their 
physicians. 
In this paper, we examine factors which influence 
how pharmacists perform this interaction monitoring 
task. Specifically, we focus on the likely contribution 
of computers, which are appearing with increasing 
frequency in community pharmacies. to pharmacists’ 
effectiveness in drug interaction monitoring. 
RESEARCH QUESTIONS 
For a pharmacist to monitor for drug interactions, 
an accurate chronological record of each of the 
patient’s medications is needed, including, for each 
medication. its strength, the directions for its use, and 
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the name of the prescriber. With this patient medica- 
tion profile (PMP), the pharmacist can review the 
patient’s active medication orders when a new drug 
is to be dispensed in order to search for other drugs 
with which the new medication might interact*, If 
a potential interaction is detected, the pharmacist 
can evaluate its significance and, if necessary, take 
measures to prevent its occurrence. In many in- 
stances, the pharmacist will need to contact the 
patient’s physician about the problem to determine if 
an alternative treatment strategy is desirable. 
Although the potential contribution of pharma- 
cists in reducing the occurrence of adverse drug 
interactions is widely recognized, many pharmacists 
still do not actively maintain PMPs or systematically 
monitor for possible interactions. We suggest three 
primary factors as influencing this aspect of pharma- 
cists’ behavior: attitude toward the importance of 
drug interaction detection, level of technical knowl- 
edge of drug interactions, and the difficulty associated 
with the monitoring and detection process. 
The clinical role of the pharmacist has been empha- 
sized in recent years. While the importance of the 
pharmacist’s role in preventing adverse drug inter- 
actions is recognized by both the pharmacy and 
medical professions [7, 81, this role is still not accepted 
by all practising pharmacists. It might be expected, 
then, that pharmacists who recognize interaction 
detection as an important aspect of their professional 
responsibilities would be more likely to perform the 
monitoring and detection function. 
Although authoritative reference manuals on drug 
interactions are available [9, lo], it is unlikely that a 
pharmacist will have knowledge of all potentially 
interacting drug combinations that exist. Reports of 
newly identified interactions among both new and 
existing medications are published frequently. Phar- 
macists must not only be aware that a specific 
interaction can occur, they must also be able to judge 
the clinical significance of the interaction in specific 
situations. 
The third factor believed to influence individual 
pharmacist’s behavior in drug interaction detection is 
the difficulty and time experienced in maintaining 
PMP records, checking these records when pre- 
scriptions are filled, and following up with prescribers 
when appropriate. These activities must be performed 
in addition to pharmacists’ more routine re- 
sponsibilities such as preparing prescriptions to be 
dispensed, obtaining payment from patients, and 
preparing third-party claims. 
Computer systems are marketed to, and purchased 
by, pharmacists primarily for business and clerical 
purposes like inventory control, prescription con- 
tainer label printing and completion of insurance 
reimbursement claims. However, most systems also 
maintain patient medication profiles and many are 
programmed to search the PMPs for potential inter- 
actions. When a potential interaction is detected by 
the computer, the pharmacist is usually provided, 
*While a complete pattent medication profile would contain 
over-the-counter drugs, in practice they usually are not 
included because of difficulties associated with maintain- 
ing reliable informatIon on patients’ use of non- 
prescription medications. 
either on the monitor screen or through identification 
of the appropriate page in an interaction reference 
book. information such as the pharmacological 
action and clinical effects of the interaction and its 
frequency of occurrence. 
Because of these capabilities. we hypothesize that 
pharmacists who use computers will be more likely to 
detect and followup on adverse drug interactions 
than those who do not. Specific questions addressed 
include: 
How do drug interaction monitoring activities vary 
between pharmacists who use computers and those 
who do not? 
Are computer users more or less likely than non- 
users to act, when potential drug interactions are 
detected, by contacting the prescriber? 
To what extent. if any, do computers influence 
pharmacists’ knowledge of drug interactions, atti- 
tudes concerning the importance of interaction de- 
tection, and perceived difficulty in detecting clinically 
significant interactions? 
METHODOLOGY 
Population description and sa.mple selection 
The population for this study consisted of pharma- 
cists who practice at least 20 hours per week in a 
community setting located in the 28 counties of 
southern Michigan. These counties were chosen be- 
cause they contain over one-half of Michigan’s phar- 
macies and represent a mix of urban and rural 
communities. 
Pharmacists included in the survey were selected 
using a stratified cluster sampling approach in which 
the primary sampling units were pharmacies. South- 
ern Michigan pharmacies were stratified into three 
groups based upon computer usage..Two groups of 
66 pharmacies each were selected randomly from 
client lists obtained from the two large pharmacy 
computer vendors (labeled Computer A and B) serv- 
ing Michigan pharmacies in the 28 county areas. 
After excluding users of Computers A and B, 80 
additional pharmacies were selected randomly from a 
Michigan Board of Pharmacy listing of all commu- 
nity pharmacies in southern Michigan. It was recog- 
nized that some pharmacies classified for sample 
selection purposes as non-users might actually be 
utilizing systems obtained from vendors other than A 
or B, but it was expected that the number of such 
pharmacies would be relatively small. The assump- 
tion was verified by the fact that 77% of respondents 
in this group reported not having a computer. Each 
sample was selected to reflect the distribution of 
pharmacies in three geographic regions: the seven- 
county Detroit metropolitan area. the seven counties 
in the middle part of the state, and the fourteen 
western counties. 
Each pharmacy was contacted individually or 
through its chain headquarters, as appropriate, for 
the names and addresses of all pharmacists practicing 
more than 20 hours per week at that site. Two chains 
and four individual pharmacies (14 pharmacies in all) 
declined to participate, leaving a total of 198 cooper- 
ating in the study. From the participating pharma- 
cies, 325 names were obtained, representing 100% of 
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the eligible pharmacists at these sites. This list consti- 
tuted the study sample. 
Survey procedure 
The results reported here are part of a larger survey 
of computer use in community pharmacy practice. 
The survey instrument included questions on the 
pharmacists’ practice characteristics, and types and 
extent of professional activities performed each day, 
and attitudes toward specific professional re- 
sponsibilities. Attitude questions were scored on 
S-point Likert scales with appropriate anchors. For 
all questions, pharmacists were requested to respond 
in terms of their personal practices rather than the 
overall practices of their pharmacies. 
As a result of a pilot test on a panel of 15 
pharmacists, including non-users and users of Com- 
puters A and B, several format and content changes 
to the questionnaire were made. The revised instru- 
ment was then distributed to pharmacists in the study 
sample using a procedure adapted from Dillman’s 
Total Design Method which employs three mailings 
[I I]. The initial and followup mailings contained a 
cover letter, a questionnaire and a stamped return 
envelope coded to allow identification of respondents 
for later mailings. Between these two mailings was a 
reminder mailing which consisted of a letter only. 
Analytical procedure 
The initial analysis, using two-tailed t-tests and x2 
tests, was designed to test general hypotheses on 
differences between computer users and non-users. 
Analysis of variance with the Scheffe statistic was 
used for inter-group comparisons among non-users, 
users of Computer A and users of Computer B. The 
resulting analysis was conservative in that it con- 
trolled for the increased probability, when doing 
multiple comparisons, of falsely concluding that a 
difference between study groups exists (‘experiment- 
wise’ error) [ 121: 
Response rate and non -response analysis 
Of 325 surveys mailed, 218 were returned yielding 
a gross response rate of 67.1% and a net response 
rate of 65.7%. Based on 213 usable responses, the 
respondent groups consisted of: Computer A, 81 
responses; Computer B, 60 responses; all other com- 
puters, 16 responses; no computer, 56 responses. 
Two analyses of non-response effects suggest that 
non-response bias was minimal. First, with additional 
data obtained from the Michigan Board of Pharmacy 
and the Michigan Pharmacists Association, re- 
spondents and non-respondents were compared using 
x’ and t-tests. on six variables: year of licensure, type 
of practice (chain or independent), school from which 
graduated. qualification as internship preceptor, sex 
and urban/rural location. The respondent and non- 
‘Pharmacw’s individual workload was calculated as: 
Workload = PIPR’[l + (HNPH’WH)] 
where PIPR is pharmacist’s individual prescription rate 
in prescriptlons per hour. HNPH is hours of non- 
professional help per day. and WH is pharmacist’s 
workday in hours. 
respondent groups were not different with respect to 
the first four of these variables. but it was found that 
females and pharmacists from rural areas were more 
likely to respond. To test whether responses might be 
biased based on sex and region of respondent, fifty 
variables from the questionnaire were examined for 
relationships with these factors. These analyses failed 
to yield any important relationships, and no evidence 
of non-response bias was found. 
The second analysis was based on the premise that 
if patterns of answers to specific questions are similar 
for individuals who responded to the initial, reminder 
and followup mailings, then the same patterns would 
hold for non-respondents. and non-response bias 
would be minimal [ 131. Forty-two variables of pri- 
mary interest were compared for respondents in the 
three groups above. In only two of the forty-two 
resulting analyses of variance was the F-value 
significant. Such a result would be expected by 
chance. Furthermore, for one variable the initial 
group was different from the other two groups, and 
for the other it was the reminder group. 
RESULTS 
The principal hypothesis of this study is that 
detection and followup of potential drug interactions 
will be improved by pharmacists’ use of pharmacy 
computer systems. This hypothesis is investigated by 
comparing groups of computer users and non-users 
in terms of responses to questions concerning atti- 
tudes and activities related to drug interactions. To 
determine whether the observed differences between 
groups in drug interaction activities might be attrib- 
uted to factors other than pharmacists’ use of com- 
puters, user and non-user groups first were compared 
in terms of their personal and work-setting character- 
istics. In terms of respondents’ sex, level of pharmacy 
education, years in practice, school attended, average 
number of prescriptions dispensed per hour and 
individual workload*, no significant differences were 
found between non-users and users of Computer A, 
users of Computer B, or the combined group of all 
computer users. Similarly, Computer A users did not 
differ from Computer B users on any of these attri- 
butes. Because of the small number of pharmacists 
using computer systems other than A or B, these 
users were not compared as a sc:parate group to the 
non-user and the Computer A and Computer B 
groups. However, they were included for com- 
parisons between users and non-users. 
In comparing characteristics of the pharmacies in 
which respondents practised, no significant 
differences were found among Computer A users, 
Computer B users and non-users in terms of the 
percentage of total sales represented by drugs and 
medical supplies. The pharmacies of Computer A 
users and Computer B users were not different in 
terms of percentage of prescriptions covered by third- 
party payors, total volume of prescriptions processed 
per hour and length of time the computer system had 
been installed. Pharmacies with computers appeared 
to process more prescriptions per hour than pharma- 
cies not using computers, although, as noted above, 
prescription volume for individual pharmacists was 
not different among any of the groups. While Com- 
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puter B users reported a higher proportion of their 
prescription volume covered by third-party payors 
(66%) than did non-users (59%), this difference does 
not appear to be of practical significance. 
In terms of type of practice (chain versus indepen- 
dent), several differences were found among the 
groups. Fifty-eight percent of Computer A users were 
employed in chain stores compared to 34% of non- 
users and only 9% of users of Computer B. Although 
the reasons for these differences are not known, they 
perhaps reflect different marketing strategies of com- 
puter system vendors. To determine whether type of 
practice was significant in explaining variability in 
any of the behavioral variables of interest, an analysis 
of variance was performed on each of the measures 
relating to drug interaction detection and followup 
activities. However, no significant effects were found, 
indicating that the differences, described below, in 
pharmacists’ activities and attitudes concerning pre- 
vention of drug interactions appear not to be attri- 
butable to the pharmacists’ personal characteristics 
or to characteristics of their practice settings, other 
than the use of a computer system. 
To investigate whether pharmacists’ use of com- 
puters helps explain the differences, a series of com- 
parisons among non-users and users of computers A 
and B were performed. These results are presented in 
three areas. First, the likelihood of pharmacists de- 
tecting potential drug interactions is examined, along 
with pharmacists’ attitudes toward this activity. Sec- 
ond, pharmacists’ followup actions, in terms of con- 
tacting prescribers when potential drug interactions 
are detected, are described. The final section consid- 
ers the impact of the computer and other sources of 
drug interaction information on pharmacists’ knowl- 
edge of potential interactions. 
Activities and attitudes concerning drug interaction 
detection 
When asked how frequently they encountered po- 
tential drug interactions, computer users reported an 
average of 16.1 interactions detected per week com- 
pared to 8.7 for non-users. The difference between 
these two averages, although substantial, was not 
statistically significant due to a large difference in 
detection rates between users of computers A and B. 
Users of Computer A reported an average detection 
rate of 23.6 drug interactions per week, while the 
average rate for users of Computer B was only 7.3 per 
week. The rate for Computer A users was 
significantly greater than that for non-users 
(P < 0.05) as well as that for Computer B users 
(P < 0.10); rates for non-users and Computer B 
users were not significantly different. These patterns 
do not appear to be attributable to differences in 
prescription volume since individual prescriptions 
dispensed per hour was not significantly different 
between computer users and non-users or between 
.users of Computers A and B. 
Similar results were observed in respondents’ views 
concerning the extent to which the detection of 
clinically significant drug interactions had increased 
during the past year. As shown in Table 1. computer 
users as a group reported a significantly greater 
increase than non-users. However, as in the question 





















Drug interactions and pharmacy computers 
increases reported by Computer A users. The extent 
of increase in drug interactions detected by Computer 
B users was not significantly greater than that of 
non-users. 
To determine pharmacists’ views more directly 
regarding the usefulness of computers in detecting 
potential drug interactions, respondents were asked 
to indicate their perceptions of the degree of difficulty 
involved in detecting potential drug interactions and 
the extent to which the pharmacy computer (if appli- 
cable) contributed to the detection process. Both 
Computer A users and Computer B users reported 
significantly less difficulty than non-users in detecting 
potential interactions, and this same result was ob- 
tained when the group of all computer users was 
compared to non-users (see Table 1). However, con- 
sistent with previous findings, pharmacists using 
Computer A reported significantly less difficulty in 
detecting interactions and rated the contribution of 
the computer to the detection process significantly 
higher than did Computer B users. 
when drug interaction or allergy problems were de- 
tected, respondents were asked to indicate the percent 
of their total prescriber contacts which were for 
discussing a drug interaction or allergy problem. 
Respondents also provided an estimate of the total 
number of prescriber contacts they make per day. As 
a group, computer users when compared to non-users 
were found to have significantly niore contacts per 
day with prescribers (21.5 vs 16.0, respectively, 
P < 0.05), and a significantly higher percentage of 
their contacts were related to interaction and allergy 
problems (3.9% vs 2.8% respectively, P < 0.05). The 
higher percentage of such contacts by computer users 
appears to be due primarily to the Computer A 
group, which reported an average of 4.4% of contacts 
for this purpose; the average percentage for Com- 
puter B users (3.0%) was not significantly different 
from that of non-users. 
Computer’s contribution to knowledge of drug inter- 
actions 
Attitudes toward the importance of detecting drug 
interactions were assessed in two ways. First, phar- 
macists were asked directly about their opinions on 
the importance of detecting clinically significant drug 
interactions. As shown in Table 1, this function was 
considered important by all respondent groups, al- 
though it was viewed most positively by Computer A 
users. Second, the pharmacists were asked to rate the 
relative importance of 18 common applications of 
computer systems, including professional (e.g. warns 
of drug allergies), clerical (e.g. prints labels) and 
administrative (e.g. provides accounts receivable 
reports). All groups of computer users as well as 
non-users rated the ‘warns of drug interactions’ func- 
tion as one of the most important. For non-users, this 
function was tied with ‘provides tape-to-tape third 
party billing’ as the most important function. 
When asked whether their knowledge of drug 
interactions had changed during the past year, 81.5% 
of the Computer A users indicated that their knowl- 
edge in this area had increased. This was a higher 
percentage than that for non-users (75.5%) and 
significantly higher (P < 0.05) than the 68.8% 
of Computer B users reporting an increase in 
knowledge. 
Prescriber contacts regarding detected interactions 
Pharmacists commonly contact prescribing phys- 
icians by telephone for such purposes as clarification 
of prescription instructions or obtaining refill author- 
izations. Pharmacists also may contact prescribers 
regarding possible problems with prescriptions, such 
as when potential drug interactions or patient allergic 
reactions are detected. In such cases, the pharmacist 
may inform the physician of the problem and, as 
appropriate, discuss possible changes in therapy. 
To investigate whether pharmacists who used com- 
puters were more or less likely to contact prescribers 
Current information on drug interactions may be 
obtained by pharmacists from a variety of sources. 
To maintain or upgrade their knowledge in this area, 
pharmacists may consult books and other printed 
materials; also, they may communicate with pharma- 
cists and other health professionals, attend con- 
tinuing education seminars, and learn from experi- 
ence with pharmacy computer systems. As shown in 
Table 2, when rating different sources of information 
in terms of relative contribution to respondents’ 
knowledge of specific drug interactions, Computer A 
users rated the computer highest of the seven sources 
listed. This rating was significantly higher than that 
given the computer by users of Computer B, who 
suggested that the computer was a less important 
information source than journal articles, continuing 
education seminars, pharmacy and medical books 
and drug interaction references. Excluding the com- 
puter, which was not an applicable source of informa- 
tion for non-users, there were no significant 
differences in the ratings given the various sources by 
Computer B users and by non-users. 
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Table 2. Contributions to pharmacists’ knowledge of drug interactions since pharmacy school graduation 
Information source 
Pharmacy computer 
Drug interaction book(s) 
Journal articles 
Continuing education seminar 
Other pharmacy/medical books 
Conversations with pharmacists 
and other health professionals 
Manufacturers’ reoresentatives 
Relative importance of sourcet Significance of differences1 
Camp. A/ Camp. B: All camp./ Camp. A/ 
Camp. A Comp. B All camp. Non-camp. non-camp. non-camp. non-camp. camp. B 
3.74 2.88 3.32 NA NA NA NA l * 
3.49 2.90 3.20 2.83 *** NS l l * 
2.95 3.42 3.19 3.25 NS NS NS NS 
2.99 3.40 3.15 3.16 NS NS NS NS 
2.77 3.20 2.92 3.09 NS NS NS NS 
2.80 2.73 2.75 2.59 NS NS NS NS 
2.25 2.76 2.44 2.40 NS NS NS L. 
*Measured on S-point scale ranging from I = no contribution to 5 = major contribution. 
ZSlgnificance levels: NA-not applicable: NS-not significant; * P < 0.10: l * P < 0.05; l ** P < 0.01, 
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Table 3. Availabtlity m pharmacy of drug interaction references 
% of respondents having references Significance of differences: 
Non- Comp. A. Comp. B. All camp. 
References Comp. A Comp. B All camp. camp. non-camp. non-camp. non-camp. 
One or both of the two 
principal referencest 92.6 76.7 86. I 63.6 *** NS *** 
Any reference 97.5 91.7 94.9 81.8 *** NS **. 
tAmerican Pharmaceutical Assoaation. Emharion of Drug Inreracrmns [9]: Honsren, Drug Inrera~tt~n~ [IO] 





Also, drug interaction books were rated 
significantly more important by Computer A users 
than by either non-users or users of Computer B. It 
is likely that ratings given for drug interaction refer- 
ences might be influenced by the types of information 
actually available in respondents’ pharmacies. As 
shown in Table 3, at least one of the authoritative 
references on drug interactions [9, lo] was routinely 
available to the majority of respondents in each 
group. As might be expected given the ratings in 
Table 2, Computer A users were more likely than 
Computer B users and significantly more likely than 
non-users to have at least one of these references on 
hand. Although not statistically significant, the pro- 
portion of Computer B users with drug interaction 
information available in their pharmacies was greater 
than the proportion for non-users. 
Computer users reported consulting these sources 
more frequently than non-users (5.3 vs 4.0 times per 
week, respectively), but this difference was not 
significant. A similar pattern was observed between 
users of Computer A and B (5.9 and 5.1 times/week, 
respectively). It is interesting to note that even for the 
group reporting the most frequent use of the books, 
Computer A, the rate of referral was only once per 
day. 
DISCUSSION AND CONCLUSION 
The survey results suggest that the principal 
hypothesis of this study, that pharmacy computers 
promote increased detection and followup of drug 
interactions, cannot be accepted. One system, Com- 
puter A, appears to support and encourage pharma- 
cists in this activity. The other computer system 
apparently has little effect. 
The average frequency with which drug inter- 
actions were encountered by pharmacists who use 
computers was found not to be significantly different 
from the average frequency for pharmacists who do 
not use computers. Users of Computer A detected 
significantly more potential interactions than did 
non-users, but the number detected by users of 
Computer B was very nearly equal to that of non- 
users. Likewise, the increase reported for the previous 
year in rate of detection of drug interactions was 
greater for computer users than for non-users, but 
this difference is attributable to the greater increase 
for users of Computer A. The change for Computer 
B users was not significantly different from that of 
non-users. 
The data show that for computer users the propor- 
tion of prescriber contacts which relate to drug 
problems (interactions, allergies) was significantly 
greater than the proportion for non-users. However, 
when non-users were compared to users of Computer 
A and B separately, it was seen that the difference was 
significant only for users of Computer A. Again, the 
proportion for Computer B users was similar to that 
of non-users. 
These patterns may be. attributable to differences in 
pharmacists’ perceived difficulty in detecting drug 
interactions or differences in pharmacists’ knowledge 
of interactions. Although non-users reported a 
greater degree of difficulty in detecting potential drug 
interactions than did users of either Computer A or 
B, the Computer A group was different from the B 
group in that Computer A users reported 
significantly less difficulty, and they rated the con- 
tribution of the computer to their drug detection 
activities higher. The proportion of respondents who 
reported that their knowledge of drug interactions. 
had increased during the previous year was greatest 
for Computer A users, and the proportion for Com- 
puter B users was smaller (although not significantly) 
than that of non-users. Non-users and Computer B 
users were similar to each other and different from 
Computer A users in their rankings of the importance 
of various sources of information on drug inter- 
actions. Users of Computer A ranked the computer 
as the most important source of information on drug 
interactions. 
As noted above, non-users and users of Computers 
A and B do not differ in terms of personal character- 
istics such as education level and years of practice. 
While the proportion of Computer A users working 
in chain-store pharmacies is significantly greater than 
that for Computer B users and non-users, there is 
no reason to believe that pharmacists practising in 
chain store settings would be more likely than other 
pharmacists to detect potential drug interactions or 
to act upon those detected by contacting prescribers. 
Furthermore, analyses failed to show any significant 
relationship between practice setting and frequency 
of drug interaction detection, proportion of pre- 
scriber contacts relating to drug problems, or other 
major variables investigated. Therefore, it seems 
reasonable to hypothesize that differences observed in 
this study between Computer A users and other 
respondents are attributable to the computer system 
used. 
While the scope of the present study does not allow 
us to identify those specific characteristics which 
make Computer A more effective than Computer B 
in supporting drug interaction detection and follow- 
up, we can speculate on some of the differences 
between the two systems. One difference which might 
influence monitoring behavior is the manner in which 
the pharmacist is referred to drug interaction refer- 
ences. When a potential interaction is detected, Com- 
puter A refers the pharmacist directly to a specific 
Drug interactions and pharmacy computers 
page in one of the standard drug interaction books, 
which can be purchased from the computer vendor. 
Computer B, on the other hand. refers the user to the 
vendor’s own manual. This book. in addition to 
summarizing the interaction, identifies relevant pages 
in the standard references if more information is 
desired. Although differences were not significant in 
all cases, compared to other respondents. users of 
Computer A were more likely to possess one or more 
of the standard reference books, tended to refer to 
these books with greater frequency. were more likely 
to report that their knowledge of drug interactions 
had increased during the previous year, and report- 
edly detected and followed up on more interactions. 
Another design characteristic which might con- 
tribute to differences in pharmacists’ detection 
activities is the manner in which the pharmacist is 
informed by the computer of potential interactions. 
For example. Computer A presents the pharmacist 
with information on both drugs involved in a poten- 
tial interaction. Although Computer B indicates to 
the pharmacist that a potential drug interaction 
exists, it does not immediately identify which of the 
patient’s current medications might interact with the 
newly-ordered drug. That information can be ob- 
tained if the pharmacist directs the computer to 
display a new screen on which the patient’s medica- 
tion profile is presented with the interacting drugs 
highlighted. 
The number of potential drug interactions included 
in the computer database is another factor which 
might influence a system’s effectiveness in supporting 
drug interaction detection. However, since the sys- 
tems of both Computer A and B are based upon 
well-documented, comprehensive reference sources, 
there should be little difference between the two in the 
completeness of the data bases utilized. 
Completeness may also be considered from a some- 
what different perspective. If achieved at the cost of 
selectivity, completeness is not necessarily a desirable 
characteristic. For pharmacists in each of the re- 
spondent groups, the most commonly cited reason 
for choosing not to contact the prescriber when a 
potential drug interaction had been detected was the 
pharmacist’s belief that harmful effects were unlikely 
to occur from that interaction. This finding suggests 
that a computer which identifies large numbers of 
interactions, including many which are generally not 
significant. may lead pharmacists to pay less atten- 
tion to all warnings, including problems which are 
clinically more important. Thus, effectiveness of a 
pharmacy computer’s drug interaction component 
might be greater if identification were limited to 
interactions which were more likely to be of clinical 
*The selectivity issue is currently being investigated in a 
followup project to the research reported here. To test 
the importance of selectivity on pharmacists’ use of drug 
interaction warning systems. a hospital pharmacy com- 
puter system has been modified so that detected inter- 
actions are flagged at one of three levels according to 
potential seriousness. and those with high potential for 
harm. as documented in the pharmacy and/or medical 
literature. cause the system to terminate medication 
order entry. Results of this project will be reported when 
available. 
significance. Since a detailed comparison of the 
specific drug interactions detected and reported by 
Computers A and B was beyond the scope of the 
current project, the degree to which differences in 
warning selectivity may have contributed to observed 
differences between users of A and B is not known. 
The findings of this study highlight the need for 
further research. Detection and followup on potential 
drug interactions is an important aspect of pharma- 
cists’ professional responsibilities. Clearly, Computer 
A is supportive of pharmacists’ efforts in this area 
while Computer B is not, and this difference appears 
to be due to specific design characteristics of the two 
systems. Additional research is needed to identify 
which characteristics are important in drug inter- 
action detection and how they relate to pharmacists’ 
attitudes and activities. Characteristics suggested by 
differences between Computers A and B in this study 
include: the specificity and completeness of reference 
sources to which pharmacists are directed when 
interactions are detected, the ease with which phar- 
macists can identify specific drugs involved when 
potential interactions are signaled, and the selectivity 
of the system as indicated by the proportion 
of signaled interactions which are of clinical 
significance*. 
There are, of course, many factors not measured in 
this study which may influence pharmacists’ ability or 
willingness to monitor for drug interactions. Atti- 
tudes of pharmacy management, receptiveness of 
prescribers toward suggestions made by pharmacists, 
and financial incentives to fill prescriptions may all be 
as important as computer system characteristics in 
promoting or discouraging drug interaction detection 
and followup. It would seem that efforts to refine 
computerized drug interaction monitoring should not 
be delayed until problems associated with these other 
factors are resolved, but rather should proceed con- 
currently. Such efiorts will not only improve the 
quality of drug interaction monitoring systems, but 
data from these systems may prove useful in pro- 
moting solutions to other problems preventing the 
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